BioElectronics BIEL · USD

Its shares trade under the ticker BIEL. It has been listed since 12 April 2004. In the fiscal year to 31 December 2025, it reported revenue of $510,623 and a net loss of $532,487. At that date it held total assets of $142,362 and shareholders' equity of −$17.9m.

BioElectronics Corp. engages in the development of wearable, nueromodulation devices for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications. The company is headquartered in Frederick, Maryland. The company went IPO on 2004-04-12. The firm is a developer, marketer and manufacturer of non-invasive electroceutical medical devices. Its devices consist of a microchip, battery and antenna, and use therapies of heat and electric restoration of the body's injured cells. Its devices are used to treat acute and chronic pain, as well as to promote wound healing. Its products include ActiPatch for Musculoskeletal Pain, Smart Insole for Foot Care, Allay for Menstrual Pain, RecoveryRx for Chronic Wounds and Postoperative Recovery, and HealFast for cats, dogs and horses. ActiPatch is a pain therapy for a range of common conditions causing pain, including osteoarthritis, rheumatoid arthritis and fibromyalgia. Its Smart Insole consists of Electro-Pulse micro medical devices that are embedded in heel gel inserts. Its Allay is a micro medical device that uses Electromagnetic Pulse Therapy to reduce menstrual pain and discomfort.

Figures and description from our data supplier, not checked against the company's own report.

• Dr. Richard StaelinChairman of the Board, since 2005
• Ms. Kelly WhelanPresident, Chief Executive Officer, Treasurer, Director, since 2019
• Mr. Keith NalepkaVice President - Sales, Director, since 2019
• Mr. John MartinezVice President - Engineering
• William MonnVice President - Production
• Ben FichterMarketing Manager
• Dr. Ian RaweDirector - Clinical Research
• Dr. Sree KoneruDirector
• Paul KnopickInvestor Relations Contact Officer

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.